§ 21-2B-02. Manufacturer’s rights and duties; informed consent form
West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2017
Effective: October 1, 2017
MD Code, Health - General, § 21-2B-02
§ 21-2B-02. Manufacturer’s rights and duties; informed consent form
(a) A manufacturer of an investigational drug, biological product, or device may:
(b)(1) Any payment required by a manufacturer under subsection (a)(2) of this section shall be limited to the recovery of the costs of or associated with the manufacture of the specific investigational drug or biological product dosages or devices provided to the eligible patient.
Notification of side effects or risks discovered while using investigational drug, biological product, or device
(c) After the date that an eligible patient begins taking or using the investigational drug, biological product, or device and during the time the eligible patient is taking or using the investigational drug, biological product, or device, the manufacturer shall notify the eligible patient and the eligible patient's health care provider of any side effects or risks associated with the investigational drug, biological product, or device that are required to be disclosed to the United States Food and Drug Administration during the drug approval process.
(d)(1) The Office of the Attorney General shall develop an informed consent form that:
Credits
Added by Acts 2017, c. 771, § 1, eff. Oct. 1, 2017.
MD Code, Health - General, § 21-2B-02, MD HEALTH GEN § 21-2B-02
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |